Diabetes and benign prostatic hyperplasia: Emerging clinical connections

Current Urology Reports

Volumn 10, Issue 4, 2009, Pages 267-275

  Sarma, Aruna V ^a   Parsons, J Kellogg ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SEX HORMONE;

CELL PROLIFERATION; CLINICAL ASSESSMENT; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ASSOCIATION; DNA SYNTHESIS; HUMAN; INFLAMMATION; LOWER URINARY TRACT SYMPTOM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POPULATION BASED CASE CONTROL STUDY; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PUBLIC HEALTH; REVIEW; SYMPATHETIC TONE; UNITED STATES;

DIABETES COMPLICATIONS; HUMANS; MALE; PROSTATIC HYPERPLASIA; PROSTATISM;

EID: 68149137253     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-009-0044-5     Document Type: Review

References (46)

1. Wei JT, Calhoun EA, Jacobsen SJ: Benign prostatic hyperplasia. In Urologic Diseases in America. Edited by Litwin MS, Saigal CS. Washington DC: US Dept of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, US Government Publishing Office; 2004:43-70.
2. S.J. Berry D.S. Coffey P.C. Walsh L.L. Ewing 1984 The development of human benign prostatic hyperplasia with age J Urol 132 474 479 (Pubitemid 14026148)
3. S. Rohrmann E. Smit E. Giovannucci E.A. Platz 2005 Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III) Int J Obes (Lond) 29 310 316 (Pubitemid 40333230)
4. J. Hammarsten B. Hogstedt 2001 Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia Eur Urol 39 151 158 (Pubitemid 32171181)
5. J. Hammarsten B. Hogstedt 1999 Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia Blood Press 8 29 36 (Pubitemid 29278945)
6. J. Hammarsten B. Hogstedt N. Holthuis D. Mellstrom 1998 Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia Prostate Cancer Prostatic Dis 1 157 162 (Pubitemid 128545860)
7. J. Hammarsten B. Hogstedt 2005 Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer Eur J Cancer 41 2887 2895 (Pubitemid 41713128)
8. H. Nandeesha B.C. Koner L.N. Dorairajan S.K. Sen 2006 Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia Clin Chim Acta 370 89 93 (Pubitemid 44080171)
9. J.K. Parsons H.B. Carter A.W. Partin 2006 Metabolic factors associated with benign prostatic hyperplasia J Clin Endocrinol Metab 91 2562 2568 (Pubitemid 44024618)
10. T.A. Boon G.E. Van Venrooij M.D. Eckhardt 2001 Effect of diabetes mellitus on lower urinary tract symptoms and dysfunction in patients with benign prostatic hyperplasia Curr Urol Rep 2 297 301
11. R.J. Glynn E.W. Campion G.R. Bouchard J.E. Silbert 1985 The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study Am J Epidemiol 121 78 90 (Pubitemid 15150691)
12. J.P. Burke D.J. Jacobson M. [tmp] McGree 2006 Diabetes and benign prostatic hyperplasia progression in Olmsted County, Minnesota Urology 67 22 25 (Pubitemid 43069248)
13. A.P. Chokkalingam Y.T. Gao J. Deng 2002 Insulin-like growth factors and risk of benign prostatic hyperplasia Prostate 52 98 105 (Pubitemid 34663322)
14. A.V. Sarma C.A. Jaffe D. Schottenfeld 2002 Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among black men Urology 59 362 367 (Pubitemid 34189735)
15. B.E. Klein R. Klein K.E. Lee R.C. Bruskewitz 1999 Correlates of urinary symptom scores in men Am J Public Health 89 1745 1748 (Pubitemid 29508227)
16. S. Sidney C. Quesenberry Jr M.C. Sadler 1991 Risk factors for surgically treated benign prostatic hyperplasia in a prepaid health care plan Urology 38 13 19
17. J.B. Meigs B. Mohr M.J. Barry 2001 Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men J Clin Epidemiol 54 935 944 (Pubitemid 32771319)
18. S.K. Van Den Eeden A.V. Sarma B.N. Rutledge 2009 Effect of intensive glycemic control and diabetes complications on lower urinary tract symptoms in men with type 1 diabetes: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study Diabetes Care 32 664 670
19. J.S. Brown H. Wessells M.B. Chancellor 2005 Urologic complications of diabetes Diabetes Care 28 177 185 (Pubitemid 40095802)
20. K. Sasaki N. Yoshimura M.B. Chancellor 2003 Implications of diabetes mellitus in urology Urol Clin North Am 30 1 12 (Pubitemid 36158465)
21. C. Frimodt-Moller 1980 Diabetic cystopathy: epidemiology and related disorders Ann Intern Med 92 318 321 (Pubitemid 10117600)
22. A.V. Sarma J.P. Burke D.J. Jacobson 2008 Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling black and white men Diabetes Care 31 476 482
23. M.C. Michel L. Mehlburger H. Schumacher 2000 Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia J Urol 163 1725 1729 (Pubitemid 30366722)
24. S. Rohrmann E.A. Platz E. Giovannucci 2005 Lifestyle and benign prostatic hyperplasia in older men: what do we know? J Mens Health Gend 2 230 235 (Pubitemid 41755130)
25. K.T. [tmp] McVary A. Rademaker G.L. Lloyd P. Gann 2005 Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia J Urol 174 1327 1433
26. P. Cohen D.M. Peehl R.G. Rosenfeld 1994 The IGF axis in the prostate Horm Metab Res 26 81 84 (Pubitemid 24089214)
27. J. Sauver S. Jacobsen 2008 Inflammatory mechanisms associated with prostatic inflammation and lower urinary tract symptoms Curr Prostate Rep 6 67 73
28. S. Furukawa T. Fujita M. Shimabukuro 2004 Increased oxidative stress in obesity and its impact on metabolic syndrome J Clin Invest 114 1752 1761 (Pubitemid 40385531)
29. G. Kramer D. Mitteregger M. Marberger 2007 Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 51 1202 1216 (Pubitemid 46436310)
30. A. Sciarra S.F. Di S. Salciccia 2007 Inflammation and chronic prostatic diseases: evidence for a link? Eur Urol 52 964 972 (Pubitemid 47332058)
31. K.S. Coyne S.A. Kaplan C.R. Chapple 2009 Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS BJU Int 103 24 32
32. E.T. Kok B.W. Schouten A.M. Bohnen 2009 Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen study J Urol 181 710 716
33. M.R. Safarinejad 2008 Prevalence of benign prostatic hyperplasia in a population-based study in Iranian men 40 years old or older Int Urol Nephrol 40 921 931
34. H.K. Park H.W. Lee K.S. Lee 2008 Relationship between lower urinary tract symptoms and metabolic syndrome in a community-based elderly population Urology 72 556 560
35. Temml C, Obermayr R, Marszalek M, et al.: Are lower urinary tract symptoms influenced by metabolic syndrome? Urology 2009 (in press).
36. A.P. Berger M. Deibl E.J. Halpern 2005 Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia Diabetologia 48 784 789 (Pubitemid 40591237)
37. J. Hong S. Kwon H. Yoon 2006 Risk factors for benign prostatic hyperplasia in south Korean men Urol Int 76 11 19 (Pubitemid 43087515)
38. A. Zucchetto A. Tavani M.L. Dal 2005 History of weight and obesity through life and risk of benign prostatic hyperplasia Int J Obes (Lond) 29 798 803 (Pubitemid 40897017)
39. M. Bozlu E. Ulusoy S. Cayan 2004 A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes Scand J Urol Nephrol 38 391 395 (Pubitemid 39551348)
40. K. Yoshimura N. Terada Y. Matsui 2004 Prevalence of and risk factors for nocturia: analysis of a health screening program Int J Urol 11 282 287 (Pubitemid 38758143)
41. M.A. Joseph S.D. Harlow J.T. Wei 2003 Risk factors for lower urinary tract symptoms in a population-based sample of African-American men Am J Epidemiol 157 906 914 (Pubitemid 36555050)
42. S.E. Dahle A.P. Chokkalingam Y. Gao 2002 Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia J Urol 168 599 604 (Pubitemid 34793304)
43. J. Hammarsten B. Hogstedt 2001 Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia Eur Urol 39 151 158 (Pubitemid 32171181)
44. J. Koskimaki M. Hakama H. Huhtala T.L. Tammela 2001 Association of non-urological diseases with lower urinary tract symptoms Scand J Urol Nephrol 35 377 381 (Pubitemid 33095946)
45. D. Prezioso C. Catuogno P. Galassi 2001 Life-style in patients with LUTS suggestive of BPH Eur Urol 40 9 12 (Pubitemid 34701699)
46. M.C. Michel L. Mehlburger H.U. Bressel 1998 Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms: does co-morbidity alter tolerability? J Urol 160 784 791 (Pubitemid 29479514)